Alzheimer’s disease is a devastating condition that affects more than 7 million Americans, according to the Alzheimer’s Association. As the Baby Boomer generation ages, this number is estimated to ...

In clinical trials, the Lumipulse blood test was highly accurate at detecting brain plaques tied to Alzheimer’s disease, which paved the way for FDA approval. Compared to brain scans and spinal taps ...

The Alzheimer’s Association estimates that 7.2 million Americans ages 65 and older—that’s about one in nine people—are living with Alzheimer's, per a 2025 report. The crippling neurological disease ...

The problems of accuracy, privacy, and access to follow-up care mean the new diagnostics available online fall short of an ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...

The earlier Alzheimer’s disease can be diagnosed, the better the outcomes; however, it can be hard to diagnose the disease in its earliest stages. The United States Food and Drug Administration ...

The roadmap to fighting Alzheimer’s disease is a matter of updating government policy to match the current science.

A new brainwave test could detect early signs of Alzheimer’s years before diagnosis — in just three minutes. That’s according to researchers at the University of Bath and the University of Bristol, ...

Scientists discovered that certain blood proteins linked to brain injury and inflammation strongly correlate with early signs of memory and cognitive decline, especially in Hispanic and Latino adults.